What’s New in Treatment for Acute Myeloid Leukemia (AML)
Audio is streamed directly from the publisher (media.blubrry.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Recorded on January 15, 2021
Join Drs. Wendy Stock and Olatoyosi Odenike from The University of Chicago Medicine, in an important discussion on the progress in the treatment of acute myeloid leukemia, including important updates from the LLS Beat AML Master Trial. Drs. Stock and Odenike talk with Dr. Ken Miller about determining a treatment plan for each patient, the role genetics and epigenetics may play, what the ultimate goals of care are, including having difficult conversations with patients regarding treatment, and monitoring for measurable residual disease and maintenance therapy. Be a part of the conversation today!
 |
Olatoyosi Odenike, MD Professor of Medicine Director, Leukemia Program Section of Hematology/Oncology The University of Chicago Medicine Chicago, IL |
|
Wendy Stock, MD Anjuli Seth Nayak Professor of Leukemia Research The University of Chicago Medicine Chicago, IL |